← Evidence map

ArticleBMC cancer2023

Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.

Xueyan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37221457